Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

New research talks about a promising adjunctive treatment to help people to build a life that isn't run by OCD.

Most women experience the effects of menopause firsthand. However, the choice of treatment can be complicated, and research shows both benefits and risks.

A low-dose, single-pill combination proved to be as effective as — and in some cases, superior to — standard-dose monotherapy ...

The device is administered as a swallowable capsule that is filled with liquid by a physician and naturally leaves the body after approximately 4 months.

Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...

Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, ...

Leading Sleep Surgeon Dr. Jordan Weiner Brings Cutting-Edge CPAP Alternative to Arizona Patients Not every state has a ...

One of the most promising is its cardiovascular disease therapy candidate CTX310, a single-treatment gene therapy that has ...

Starting biologic therapy at diagnosis, rather than escalating later, may significantly reduce complications and ...

FAYETTEVILLE, GA, UNITED STATES, January 26, 2026 /EINPresswire.com/ -- Postoperative recurrence remains the main ...